Group One Trading
VERA icon

Group One Trading’s Vera Therapeutics VERA Stock Holding History

Group One Trading’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.3K Buy
+1,200
New +$51.7K ﹤0.01% 5283
2025
Q4 		– Sell
-2,000
Closed -$58.1K – 9234
2025
Q3 		$58.1K Sell
2,000
-86,800
-98% -$2.01M ﹤0.01% 5827
2025
Q2 		$2.09M Buy
88,800
+84,500
+1,965% +$1.9M ﹤0.01% 2090
2025
Q1 		$103K Sell
4,300
-10,100
-70% -$325K ﹤0.01% 4580
2024
Q4 		$609K Sell
14,400
-19,300
-57% -$855K ﹤0.01% 3009
2024
Q3 		$1.49M Buy
33,700
+3,100
+10% +$118K ﹤0.01% 1972
2024
Q2 		$1.11M Sell
30,600
-17,800
-37% -$706K ﹤0.01% 1906
2024
Q1 		$2.09M Buy
+48,400
New +$1.72M 0.01% 1448
2023
Q3 		– Sell
-4,300
Closed -$69K – 8363
2023
Q2 		$69K Buy
+4,300
New +$38.8K ﹤0.01% 4981

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Group One Trading's VERA Position: Q3 2025 in Review

Group One Trading sold out of Vera Therapeutics (VERA) in Q3 2025, closing a stake of 11,360 shares — an estimated $263K sold.

Group One Trading first reported a position in VERA in Q2 2024 and held it in 3 quarters. The position peaked at $436K in Q2 2024. 175 funds tracked by Wall St. Rank hold VERA as of Q3 2025.

  • Group One Trading reported no remaining Vera Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 11,360 Vera Therapeutics shares in Q3 2025, an estimated $263K.
  • Group One Trading first reported a position in Vera Therapeutics in Q2 2024 and held it in 3 quarters.
  • Group One Trading's Vera Therapeutics position peaked at $436K in Q2 2024.
  • 175 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.